Divi's Laboratories Ltd.
Snapshot View

3726.20 -221.85 ▼-5.6%

12 August 2022, 04:11:06 PM
Volume: 2,107,936

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.divislabs.com
Market Cap 98,972.00 Cr.
Enterprise Value(EV) 96,100.02 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 116.98 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 31.87 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 468.24 Trailing Twelve Months Ending 2022-06
Price to Book Value 7.96 Calculated using Price: 3,728.20
Dividend Yield 0.80 Period Ending 2022-03
No. of Shares Subscribed 26.55 Cr. 265,468,580 Shares
FaceValue 2
Company Profile
The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-5.62%
1 Week
-4.75%
1 Month
+1.05%
3 Month
-11.98%
6 Month
-13.17%
1 Year
-24.09%
2 Year
+19.54%
5 Year
+494.10%
10 Year
+561.46%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 28.31 26.37 28.91 21.98 15.55 21.00 19.30 23.90 28.16
Return on Capital Employed (%) 36.04 33.06 35.57 28.75 21.68 28.50 25.36 32.07 35.06
Return on Assets (%) 19.92 18.21 22.49 17.21 11.12 15.78 15.11 19.07 22.77

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 2,501 2,963 3,495 4,293 5,357 5,925 6,957 7,310 9,295 11,728
Non Curr. Liab. 470 650 842 85 1,412 1,769 991 295 364 437
Curr. Liab. 554 627 776 520 659 653 847 1,821 1,728 2,454
Minority Int.
Equity & Liab. 3,525 4,241 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619
Non Curr. Assets 1,661 1,984 2,340 1,871 3,418 3,812 4,145 3,851 4,596 5,009
Curr. Assets 1,864 2,256 2,772 3,027 4,011 4,535 4,650 5,574 6,791 9,610
Misc. Exp. not W/O
Total Assets 3,525 4,241 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 2,532 3,115 3,776 4,064 3,891 4,946 5,394 6,969 8,960 9,254
Other Income 71 45 97 75 113 156 190 63 116 177
Total Income 2,603 3,160 3,874 4,139 4,005 5,102 5,584 7,032 9,076 9,430
Total Expenditure -1,517 -1,949 -2,358 -2,617 -2,629 -3,073 -3,571 -4,108 -5,079 -5,387
PBIDT 1,086 1,211 1,516 1,522 1,376 2,029 2,013 2,924 3,997 4,043
Interest -3 -3 -5 -3 -2 -5 -7 -2 -2 -1
Depreciation -92 -136 -118 -123 -142 -169 -186 -256 -312 -322
Taxation -218 -221 -267 -335 -354 -502 -443 -682 -723 -615
Exceptional Items
PAT 773 852 1,126 1,060 877 1,353 1,377 1,984 2,960 3,105
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 773 852 1,126 1,060 877 1,353 1,377 1,984 2,960 3,105
Adjusted EPS 29 32 42 40 33 51 52 75 112 117

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 480 557 826 1,038 1,150 776 954 1,216 1,947 1,912
Cash Fr. Inv. -255 -305 -521 -406 -1,140 -478 -685 -83 75 -2,195
Cash Fr. Finan. -231 -249 -303 -631 2 -314 -246 -1,091 -35 -532
Net Change -5 3 3 0 13 -17 23 41 1,987 -816
Cash & Cash Eqvt 12 15 18 18 -4 -21 2 43 2,030 1,215

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 51.97 51.96 51.95 51.95 51.95 51.95 51.95 51.94 51.94
Public 48.03 48.04 48.05 48.05 48.05 48.05 48.05 48.06 48.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 12 Aug 2022
Outcome of Board Meeting
Divi's Laboratories Limited has informed the Exchange about Board Meeting held on 12-Aug-2022 to consider financial statements for the period ended June 2022
Fri, 12 Aug 2022
General updates
Divi's Laboratories Limited has informed the Exchange about Outcome of Board Meeting held on 12.08.2022.
Fri, 12 Aug 2022
Recording of Analysts/Institutional Investor Meet/Con. Call
Divi's Laboratories Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Fri, 12 Aug 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Abbott India Ltd. 39,867.83 18,761.95 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-06 49.31 18,761.95 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-06 13.37 18,761.95 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 18,761.95 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,761.95 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 18,761.95 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,761.95 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 18,761.95 -1.0%

FAQ's On Divi's Laboratories Ltd.

Can I Buy Divi's Lab Shares now?

What is the Share Price of Divi's Lab?

What is the Relative Strength Index (RSI) Value of Divi's Lab?

What is the Market Capital (MCAP) of Divi's Lab?

What are the key metrics to analyse Divi's Lab?

What is the Price Performance of Divi's Lab?